Evidence map›Paper›PMID 35889936›Full record

Trial reportNutrients2022

Effect of Evening Primrose Oil Supplementation on Selected Parameters of Skin Condition in a Group of Patients Treated with Isotretinoin-A Randomized Double-Blind Trial.

Agnieszka Kaźmierska, Izabela Bolesławska, Adriana Polańska, Aleksandra Dańczak-Pazdrowska, Paweł Jagielski, Sławomira Drzymała-Czyż, Zygmunt Adamski, Juliusz Przysławski

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Agnieszka KaźmierskaDepartment of Bromatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Izabela BolesławskaDepartment of Bromatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0001-6780-3105
Adriana PolańskaLaboratory of Connective Tissue Diseases, Department of Dermatology and Venereology, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Aleksandra Dańczak-PazdrowskaDepartment of Dermatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Paweł JagielskiDepartment of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 31-066 Krakow, Poland.ORCID 0000-0001-7583-8965
Sławomira Drzymała-CzyżDepartment of Bromatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0001-8291-5439
Zygmunt AdamskiDepartment of Dermatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Juliusz PrzysławskiDepartment of Bromatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Poznan University of Medical Sciences · PLJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Retinoids, which include isotretinoin, reduce sebum levels, the degree of epidermal wetness (CORN) and cause an increase in transepidermal water loss (TEWL). Weight gain has also been observed in isotretinoin-treated patients. An agent that can reduce the severity of isotretinoin side effects is evening primrose oil (Oenothera paradoxa). The purpose of this study was to evaluate the effect of evening primrose oil supplementation in patients with acne vulgaris treated with isotretinoin on skin hydration status (CORN), transepidermal water loss (TEWL), skin oiliness (sebum) and changes in body weight and BMI. Methods: Patients diagnosed with acne were assigned to the isotretinoin-treated group (n = 25) or the isotretinoin and evening primrose oil-treated group (n = 25). The intervention lasted 9 months. CORN (with a corneometer), TEWL (with a tewameter) and sebum (with a sebumeter) were assessed twice, as well as body weight and BMI (Tanita MC-780). Results: The isotretinoin-treated group showed statistically significant reductions in CORN (p = 0.015), TEWL (p = 0.004) and sebum (p < 0.001) after the intervention. In the group treated with isotretinoin and evening primrose oil, TEWL and sebum levels also decreased significantly (p < 0.05), while CORN levels increased from 42.0 ± 9.70 to 50.9 ± 10.4 (p = 0.017). A significant decrease in body weight (p < 0.001) and BMI (p < 0.001) was observed in both groups after 9 months of intervention. Conclusions: During isotretinoin treatment, supplementation with evening primrose oil increased skin hydration. However, there were no differences between groups in transepidermal water loss, skin oiliness, weight loss and BMI.

Indexed as

Acne VulgarisIsotretinoinBody WeightDietary Supplementsgamma-Linolenic AcidHumansLinoleic AcidsOenothera biennisPlant OilsSkinWaterevening primrose oilgamma-Linolenic AcidIsotretinoinLinoleic AcidsPlant OilsWateracneBody Mass Indexbody weightevening primrose oilisotretinoinsebumskin hydrationtransepidermal water loss

Identifiers

PMID35889936
PMCPMC9317771
OpenAlexW4286434164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.